This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Walgreens Boots Alliance (WBA) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 13.59% and 2.96%, respectively, for the quarter ended August 2021. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Walgreens (WBA) Ahead of Earnings?
by Zacks Equity Research
Walgreens (WBA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in Store for Commercial Metals' (CMC) Q4 Earnings?
by Zacks Equity Research
Commercial Metals' (CMC) Q4 results likely to reflect strong finished steel volumes, driven by solid construction and infrastructure demand.
Walgreens Boots Alliance (WBA) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Walgreens (WBA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Walgreens (WBA) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Faster adoption of digital health and an improved business environment are expected to have contributed to Walgreens' (WBA) fourth-quarter performance.
Here's How Investors Can Find Strong Retail and Wholesale Stocks with the Zacks ESP Screener
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Stock Market News for Oct 1, 2021
by Zacks Equity Research
Benchmarks closed in the red on Thursday despite Congress' last-minute move to prevent a partial government shutdown.
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $48.71, marking a +1.29% move from the previous day.
3 High-Potential MedTech Stocks With More Than 50% Growth YTD
by Riya Anand
Stocks like West Pharmaceuticals Services (WST), Maravai LifeSciences (MRVI) and Option Care Health (OPCH) have gained stupendously year to date.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $48.46, marking a +0.94% move from the previous day.
Here's Why You Should Retain Walgreens (WBA) Stock for Now
by Zacks Equity Research
Investors are optimistic about Walgreens (WBA), given the strong performance in the International segment and notable product launches.
Rite Aid (RAD) to Report Q2 Earnings: What Should You Know?
by Zacks Equity Research
Rite Aid (RAD) is likely to have gained from PBM, RxEvolution strategy and expanded omnichannel services in Q2. Rising wage costs and drab front-end same-store sales are likely to have been concerns.
Walgreens Boots Alliance (WBA) Stock Moves -0.64%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $49.62, moving -0.64% from the previous trading session.
Can Walgreens (WBA) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Walgreens (WBA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
How to Boost Your Portfolio with Top Retail and Wholesale Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $49.94, moving -0.36% from the previous trading session.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $50.57, moving -1.02% from the previous trading session.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $51.29, marking a -0.95% move from the previous day.
Stock Market News for Sep 3, 2021
by Zacks Equity Research
Benchmarks closed in the green on Thursday as investors rejoiced improvement in weekly jobless claims ahead of August's jobs data scheduled for release on Friday.
Stock Market News for Sep 1, 2021
by Zacks Equity Research
Benchmarks closed in the red on Tuesday as investors await jobs data for August scheduled for release on Sep 3 to trace when the Federal Reserve may begin tapering its bond purchases.
Walgreens (WBA) to Stock LUCEMYRA Across US With New Pact
by Zacks Equity Research
Walgreens' (WBA) agreement with US WorldMeds finalized as recent report outlines a surge of 30% in drug overdose deaths in 2020.
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $48.48 in the latest trading session, marking a +1.34% move from the prior day.
Walgreens (WBA) Provides Flu Shots Nationwide for Ages 3 & More
by Zacks Equity Research
Walgreens (WBA) is ready to co-administer COVID-19 vaccines and flu shots anticipating COVID-19 boosters in September.
Stock Market News for Aug 12, 2021
by Zacks Equity Research
U.S. stock markets closed mostly higher on Wednesday after Senate Democrats passed a budget resolution for the $3.5 trillion bill.
Stock Market News for Aug 5, 2021
by Zacks Equity Research
The Dow and the S&P 500 closed in the red on Wednesday weighed by a lower-than-expected private-sector jobs report and Fed's Vice Chairman Richard Clarida's comment on higher interest rates in 2023 given the current path of economic recovery.